BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,523,503 | -17.0% | 543,813 | +0.1% | 0.05% | -12.7% |
| Q2 2023 | $24,741,495 | +9.8% | 543,053 | -2.2% | 0.06% | +5.8% |
| Q1 2023 | $22,529,620 | -19.7% | 555,464 | +0.9% | 0.05% | -24.6% |
| Q4 2022 | $28,067,345 | -6.7% | 550,664 | -1.4% | 0.07% | -10.4% |
| Q3 2022 | $30,068,000 | -16.1% | 558,264 | 0.0% | 0.08% | -11.5% |
| Q2 2022 | $35,857,000 | -24.9% | 558,264 | -9.4% | 0.09% | -6.5% |
| Q1 2022 | $47,771,000 | -13.2% | 616,086 | -3.9% | 0.09% | -6.1% |
| Q4 2021 | $55,056,000 | +4.0% | 641,374 | -2.6% | 0.10% | -3.9% |
| Q3 2021 | $52,940,000 | -4.0% | 658,218 | -3.9% | 0.10% | -1.0% |
| Q2 2021 | $55,133,000 | -7.6% | 684,878 | -3.2% | 0.10% | -12.6% |
| Q1 2021 | $59,658,000 | +3.2% | 707,351 | -1.8% | 0.12% | +1.7% |
| Q4 2020 | $57,795,000 | +1.8% | 720,273 | +2.1% | 0.12% | -9.3% |
| Q3 2020 | $56,755,000 | -5.6% | 705,728 | +1.0% | 0.13% | -13.4% |
| Q2 2020 | $60,149,000 | +7.7% | 698,590 | +1.5% | 0.15% | -12.4% |
| Q1 2020 | $55,874,000 | -3.5% | 688,185 | -0.6% | 0.17% | +20.6% |
| Q4 2019 | $57,890,000 | -5.2% | 692,303 | -0.8% | 0.14% | -11.9% |
| Q3 2019 | $61,074,000 | +4.3% | 698,233 | -2.4% | 0.16% | +5.3% |
| Q2 2019 | $58,568,000 | -1.8% | 715,115 | -2.5% | 0.15% | -3.8% |
| Q1 2019 | $59,615,000 | +22.7% | 733,187 | -0.7% | 0.16% | +9.0% |
| Q4 2018 | $48,597,000 | -15.5% | 738,337 | -1.0% | 0.14% | -0.7% |
| Q3 2018 | $57,510,000 | +2.3% | 746,017 | -2.0% | 0.15% | -2.7% |
| Q2 2018 | $56,237,000 | +11.3% | 761,604 | -2.0% | 0.15% | +7.9% |
| Q1 2018 | $50,522,000 | -3.3% | 776,786 | -3.9% | 0.14% | 0.0% |
| Q4 2017 | $52,266,000 | +5.6% | 808,568 | +2.5% | 0.14% | +3.0% |
| Q3 2017 | $49,489,000 | +3.5% | 788,668 | -0.1% | 0.14% | 0.0% |
| Q2 2017 | $47,797,000 | +16.8% | 789,518 | +0.1% | 0.14% | +14.4% |
| Q1 2017 | $40,907,000 | +17.3% | 788,804 | +0.3% | 0.12% | +12.4% |
| Q4 2016 | $34,874,000 | -7.7% | 786,504 | -0.9% | 0.10% | -11.0% |
| Q3 2016 | $37,776,000 | +2.2% | 793,614 | -2.9% | 0.12% | +0.9% |
| Q2 2016 | $36,965,000 | +30.3% | 817,456 | +18.4% | 0.12% | +8.3% |
| Q1 2016 | $28,373,000 | +7.5% | 690,676 | -0.2% | 0.11% | +10.2% |
| Q4 2015 | $26,403,000 | +17.6% | 692,089 | +1.2% | 0.10% | +12.6% |
| Q3 2015 | $22,455,000 | -53.0% | 683,559 | 0.0% | 0.09% | -48.8% |
| Q2 2015 | $47,801,000 | -0.1% | 683,559 | -2.1% | 0.17% | +4.3% |
| Q1 2015 | $47,828,000 | -14.9% | 698,212 | -9.0% | 0.16% | -7.4% |
| Q4 2014 | $56,234,000 | +0.8% | 767,274 | -1.3% | 0.18% | -3.3% |
| Q3 2014 | $55,801,000 | -1.6% | 777,495 | -0.9% | 0.18% | +1.1% |
| Q2 2014 | $56,725,000 | -5.8% | 784,585 | -4.1% | 0.18% | -8.2% |
| Q1 2014 | $60,225,000 | -4.0% | 818,503 | -9.3% | 0.20% | +4.3% |
| Q4 2013 | $62,765,000 | +3.3% | 902,445 | -2.4% | 0.19% | -4.1% |
| Q3 2013 | $60,733,000 | -6.7% | 924,538 | -1.6% | 0.20% | -9.3% |
| Q2 2013 | $65,071,000 | – | 939,388 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |